Package 68180-151-06

{"route": ["ORAL"], "spl_id": "b26f08e4-dfe4-4a0f-b6b5-e9abb495e415", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "upc": ["0368180152064", "0368180151067"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300791", "1300801"], "spl_set_id": ["d22d3d12-8466-46db-bc19-d13e87c6115c"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-06)", "package_ndc": "68180-151-06", "marketing_start_date": "20240419"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-09)", "package_ndc": "68180-151-09", "marketing_start_date": "20240419"}], "brand_name": "MIRABEGRON", "product_id": "68180-151_b26f08e4-dfe4-4a0f-b6b5-e9abb495e415", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "68180-151", "generic_name": "mirabegron", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MIRABEGRON", "active_ingredients": [{"name": "MIRABEGRON", "strength": "25 mg/1"}], "application_number": "ANDA209485", "marketing_category": "ANDA", "marketing_start_date": "20240419", "listing_expiration_date": "20261231"}